Omega 3 fatty acid medicines no longer seen as effective in preventing heart disease
date:Dec 18, 2018
he dietary management of patients with NAFLD. Hepaxa increases the levels of EPA and DHA in patients with NAFLD, which improves the livers ability to process fat.

In September, Evonik received clearance to market its high-concentration omega 3 lysine powder complex AvailOm for use in the EU. AvailOm is touted as having the highest-load omega 3 powder in its class with a minimum of 45 percent EPA and DHA by weight. In addition to delivering protection against oxidation based upon three years o
4/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/07 05:32